Latest News and Press Releases
Want to stay updated on the latest news?
-
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company,...
-
THE WOODLANDS, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gulf Island Fabrication, Inc. (NASDAQ: GIFI) (“Gulf Island” or the “Company”), a leading steel fabricator and service provider to the...
-
ISELIN, N.J., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today the planned retirement of Thomas M. Lyons, Senior Executive Vice...
-
MCLEAN, Va., Jan. 13, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced its Mission Technologies division was awarded a contract for the Missile Defense Agency Scalable Homeland Innovative...
-
Commerce to Announce Fourth Quarter 2025 and Full Year 2025 Financial Results on February 12th, 2026
AUSTIN, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (“Commerce”), a provider of an open, intelligent commerce ecosystem that enables businesses to unlock data...
-
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America’s...
-
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Galectin Therapeutics Inc. (“Galectin” or the “Company”) (NASDAQ: GALT). Such investors...
-
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR). Such investors are...
-
TERRE HAUTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Hallador Energy Company (Nasdaq: HNRG), today announced that it intends to offer and sell $50 million of shares of its common stock in an...
-
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated (“Insmed” or the “Company”) (NASDAQ: INSM). Such investors are...